LYEL

Lyell Immunopharma

This biopharmaceutical company develops chimeric antigen receptor T-cell therapies to treat patients with hematologic malignancies and solid tumours.

OverT

This biotechnology company develops engineered cell therapies for the treatment of solid tumours in cancer patients.

NKIO

This company develops natural killer cell therapies and small molecule medicines to treat solid tumours for patients with cancer and inflammatory diseases.

CARGO Therapeutics

This biotechnology company develops engineered cell therapies to treat cancer patients with relapsed or resistant lymphoma.

OverT Bio

This company develops engineered cell therapies and genetic screening platforms to treat patients with solid tumour cancers.

RYZB

This company develops targeted radiopharmaceutical therapeutics for patients with solid tumours.

Vivere Oncotherapies

This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.

Captain T Cell

The company develops cell therapies for cancer patients to treat solid tumours.